Although phosphorylated tau at threonine 231 (pTau 231) is a promising blood-based biomarker for incipient Alzheimer's disease (AD), existing assays such as Simoa® are not sensitive enough to reliably ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results